{
    "2018-01-29": [
        [
            {
                "time": "2018-02-20",
                "original_text": "EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Philip Morris International Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 20, 2018 â€“ PM",
                "features": {
                    "keywords": [
                        "Class Action Lawsuit",
                        "Lead Plaintiff Deadline",
                        "Philip Morris International"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "tobacco"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Noteworthy ETF Outflows: ITOT, CMCSA, DWDP, PM",
                "features": {
                    "keywords": [
                        "ETF Outflows",
                        "PM"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "PMI Presents to US FDA Advisory Committee; Important Milestone in the Scientific Review of IQOS",
                "features": {
                    "keywords": [
                        "US FDA Advisory Committee",
                        "Scientific Review",
                        "IQOS"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "tobacco"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "New E-Cig Study Poses Risk for Philip Morris International",
                "features": {
                    "keywords": [
                        "E-Cig Study",
                        "Risk",
                        "Philip Morris International"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "tobacco"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}